Skip to content
value.today

Collegium Pharmaceutical, Inc. vs Solid Biosciences Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Collegium Pharmaceutical, Inc. and Solid Biosciences Inc. are worth about the same: $715 M and $713 M (market caps of Oct 28, 2026 for Collegium Pharmaceutical, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).
  • Collegium Pharmaceutical, Inc. made a net profit of $63 M, while Solid Biosciences Inc. made a net loss of $174 M.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01232473704932020202120222023202420252026Collegium Pharmaceutical, Inc. 102Solid Biosciences Inc. 357

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$1B$1B201720182019202020212022202320242025Collegium Pharmaceutical, Inc. $1BSolid Biosciences Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCollegium Pharmaceutical, Inc.
COLL · #10,988 in the world
Solid Biosciences Inc.
SLDB · #10,997 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded—2013
Size
Market cap$715 M$713 M
Revenue$781 M—
Net income$63 M▲ best$-174 M
Employees234—
Valuation
P/E ratio18.7×—
Price to sales0.9×—
Price to book2.4×4.0×
Free cash flow yield45.8%▲ best-22.1%
Profitability
Gross margin59.4%—
Operating margin23.0%—
Net margin8.1%—
Return on equity23.7%▲ best-109.9%
Growth
Revenue growth23.6%—
Revenue growth, 3 years a year18.9%—
Earnings per share growth-7.0%—
Cash
Free cash flow margin42.0%—
Shareholder returns
Shareholder yield3.5%—
Altman Z-score zonedistress—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Collegium Pharmaceutical, Inc. or Solid Biosciences Inc.?

Collegium Pharmaceutical, Inc. and Solid Biosciences Inc. are worth about the same: $715 M and $713 M (market caps of Oct 28, 2026 for Collegium Pharmaceutical, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).

Which makes more money, Collegium Pharmaceutical, Inc. or Solid Biosciences Inc.?

Collegium Pharmaceutical, Inc. made a net profit of $63 M, while Solid Biosciences Inc. made a net loss of $174 M.